Mind + Muscle

technical minds + legal muscle

Bracket
Sterne Kessler Goldstein Fox
"After almost 20 years as a successful therapeutic antibody technology company, we transformed into a clinical development company and we lacked expertise in patenting and life cycle management.  Tim Shea, with his extensive knowledge of the therapeutic antibody space, helped us design a complete strategy for protecting our therapeutic pipeline and assisted us with freedom to operate searches and opinions.  Tim has been our go to attorney when we enter into new areas such as antibody enhancement technologies.  He has supported us throughout multiple due diligences, and provided high quality input, often in a very short time frame, when it really mattered.  Tim was able to do this because of his own expertise and focus on service, and having a strong team with enough depth and technical expertise to handle any matter."
- Paul Wiegel
Associate Director, IP
Morphosys AG
Timothy J. Shea, Jr.

Mind + Muscle

Timothy J. Shea, Jr.

Director

 

Mr. Shea is a director in the Biotechnology/Chemical Group where he advises biotech and chemical companies and research institutions on complex legal issues relating to the protection, enforcement and transfer of their intellectual property.  He practices primarily in the fields of immunology, molecular biology, genomics, proteomics, medical diagnostics, biotherapeutics, and drug delivery.  He has extensive experience advising clients on the creation and management of strategic patent portfolios, freedom-to-operate and patentability issues, complex prosecution strategies, validity and infringement issues, and due diligence investigations in connection with acquisitions and investments. 

A significant portion of Mr. Shea's practice involves counseling emerging companies on strategies for creating, protecting and leveraging their IP assets to grow their businesses. He frequently advises clients on all aspects of technology transfer, including the drafting and negotiation of patent and technology license agreements, material transfer agreements, sponsored research agreements, confidentiality and nondisclosure agreements, joint developments agreements, etc.  Mr.  Shea is currently Vice-Chair of the Life Sciences Committee for Licensing Executives Society International, an international network of IP licensing professionals. He also serves as the Executive Editor of the Chicago-Kent Law Review.

Mr. Shea is also is a contributing author of Patent Office Litigation, Second Edition, published in 2017, the book provides a fresh and comprehensive exploration of patent office litigation proceedings, including how the proceedings interact with other aspects of patent procurement and enforcement, while delivering practical analysis and advice. This second edition of Patent Office Litigation is the follow up to the first version of the book that was published in 2012 by Thomson Reuters Westlaw that focused on the contested proceedings that were introduced under the America Invents Act that year.

Prior to attending law school, Mr. Shea worked for several years in the biotech industry in the areas of medical diagnostics and genetic profiling.

  • Admissions
      • District of Columbia

      • United States District Court for the Eastern District of Virginia

      • United States Patent and Trademark Office

      • Virginia

  • Education
    • J.D., Chicago-Kent College of Law with high honors, Order of the Coif

    • B.S., Biology, Washington & Lee University

    X

    Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.